Key drivers for each region include: for North America, adoption of 3D cell models in pharmaceutical companies, policies supporting research and development, and investments in biotechnology; for Europe, ecosystem maturity, demographics with a high percentage of elderly population, and infrastructure with well-established research institutions; for Asia Pacific, investments in research and development, government initiatives supporting biotechnology, and adoption of 3D cell models in emerging countries; for Latin America, policies supporting research and development, infrastructure development, and demographics with a growing middle class; and for Middle East & Africa, investments in biotechnology, government initiatives supporting research and development, and ecosystem maturity.